Parkinson Disease, Idiopathic
24
8
10
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 24 trials
100.0%
+13.5% vs benchmark
8%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (24)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Investigating Adaptive Deep Brain Stimulation in Parkinson's Disease Management
Parkinson's Disease Biomarker Study
An Exploratory Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disease
A High-density Microelectrode for Human Neuronal Recordings
Video-oculography and Parkinson's Disease
Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease
Integration of Augmented Visual Feedback in Action Observation and Motor Imagery Therapy for Parkinson's Disease
The Impact of Deep Brain Stimulation on Speech and Swallow Function in Parkinson Disease
SMART-PD: Evaluating the Impact of Smartphone-Based Wearable Technology on Motor Symptoms and Quality of Life in People With Parkinson's Disease
A Targeted Amino Acid Supplement for People With Parkinson's Disease
Mediterranean Diet Effects on Parkinson's Disease
Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease
Strength-Endurance Circuit Training in Parkinson's Disease
LFP Sensing From Directional Leads in the Acute Clinical Setting
Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson Disease
Neuroprotective Effects of Long-term TaVNS in Early Parkinson's Disease Patients
A Novel Robotic System for Motor-cognitive Exercise for Patients With Parkinson's Disease
Clinical Trail of Transcranial MR-guided Focused Ultrasound in the Treatment of Motor Symptoms in Patients with Parkinson' Disease
Ameliorating Effects and Mechanisms of TaVNS on Constipation in PD Patients.